Before starting a patient on prophylactic heparin or low molecular weight heparin the risk (bleeding) and benefits (avoiding DVT and PE) need to be carefully considered. Identifying patients who will definitely benefit from anticoagulation is not easy.
Page last reviewed: 22 Apr 2020
